Moreover, these results also suggest that elevated AMPK suppresses hepatic lipogenesis and ultimately liver steatosis through mTORC1-S6K1-independent mechanism(s) in obese Arg-II−/− mice. Here, RPS6KB1 is linked to fatty liver disease.